Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Protein Targeting Compounds -

Protein Targeting Compounds

Prediction, Selection and Activity of Specific Inhibitors

Thomas Böldicke (Herausgeber)

Buch | Softcover
VIII, 288 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2016
Springer International Publishing (Verlag)
978-3-319-81373-8 (ISBN)
CHF 224,65 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book presents an overview of the most relevant protein knockdown techniques. Readers will find a description of the generation and use of recombinant human antibodies, ER intrabodies and peptides as well as a description of the working mechanism and potential of the inhibitory action of each of these molecules. The book will also describe the selection and activity of a number of phosphatases, aptamers and allosteric modulators, focusing on A G protein coupled receptors. The book starts with a chapter on the in silico prediction of target-inhibitor interactions.

Key aspects of this book are:

- Selection strategies for monoclonal and recombinant human antibodies

- Selection strategies for ER intrabodies, peptides and aptamers

- Examples of the most efficient inhibitors and their applications in protein biochemistry and cell biology

- Antibodies for cancer therapy and inhibitors of angiogenesis.

The book will be of great interest to scientists and students working in the life sciences on all areas related to protein biology. The variety of methods to modulate the activities of specific proteins which are introduced here will be of great benefit to the reader who is interested in general protein research or to readers who have very specific protein related questions.

Introduction.- Part I Methods of Structure Prediction.- Chapter 1 In Silico Prediction of Target-Inhibitor Interactions.- Part II Antibodies.- Chapter 2 Antibodies and Selection of Monoclonal Antibodies.- Chapter 3 Selection of Recombinant Human Antibodies.- Chapter 4 Selection of Recombinant Human Antibodies against Toxins and Viruses.- Chapter 5 Recent Advances with ER Targeted Intrabodies.- Chapter 6 Therapeutic Blocking Antibodies against Oncogenic Receptors and Growth Factors.- Chapter 7 Synthetic Cystine-Knot Miniproteins-Valuable Scaffolds for Polypeptide Engineering.- Part III Peptides, Small Molecules and Aptamers.- Chapter 8 Peptides and Peptide Analogs to Inhibit Protein.- Chapter 9 Allosteric Modulators of the Class A G Protein coupled Receptors.- Chapter 10 Phosphatases: Their Roles in Cancer and their Chemical Modulators.- Chapter 11 Selection and Application of Aptamers and Intramers.- Part IV Angiogenesis Inhibitors.- Chapter 12 Inhibitors of Angiogenesis.

Erscheint lt. Verlag 30.5.2018
Reihe/Serie Advances in Experimental Medicine and Biology
Zusatzinfo VIII, 288 p. 49 illus., 31 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 615 g
Themenwelt Studium Querschnittsbereiche Infektiologie / Immunologie
Schlagworte Allosteric Modulators • Aptamers • Peptides • phosphatases • Recombinant antibodies
ISBN-10 3-319-81373-0 / 3319813730
ISBN-13 978-3-319-81373-8 / 9783319813738
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Oliver Schmetzer

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80